Cat.No.: 12683-1
The lung cancer core 11-gene variation combined detection product independently developed by TargetingOne covers all drug-related core genes recommended by authoritative medical guidelines such as NCCN and CSCO.Based on the digital PCR detection platform and through the two-dimensional detection of “DNA + RNA”, it comprehensively screens for hotspot mutations in the core driver genes of non-small cell lung cancer (NSCLC), accurately guides targeted therapy for NSCLC patients, and provides clinics with a core, accurate, economical and rapid solution.
